Genotype-controlled analysis of serum dopamine β-hydroxylase activity in civilian post-traumatic stress disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 8, 2010, Pages 1396-1401

  Tang, Yi Lang ^a   Li, Wenbiao ^a   Mercer, Kristina ^c   Bradley, Bekh ^a,b   Gillespie, Charles F ^a   Bonsall, Robert ^a   Ressler, Kerry J ^a,c,d   Cubells, Joseph F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

Depression; Genotype; Post traumatic stress disorder; Serum dopamine hydroxylase

Indexed keywords

DOPAMINE BETA MONOOXYGENASE;

ADULT; AFRICAN AMERICAN; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGICAL RATING SCALE;

ADULT; BIOLOGICAL MARKERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINE BETA-HYDROXYLASE; ENZYME ACTIVATION; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; STRESS DISORDERS, POST-TRAUMATIC; VETERANS; WAR;

EID: 78649507450     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.07.002     Document Type: Article

References (43)

1. Bernstein D.P., Fink L., Handelsman L., Foote J., Lovejoy M., Wenzel K., et al. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry 1994, 151:1132-1136.
2. Bernstein D.P., Ahluvalia T., Pogge D., Handelsman L. Validity of the Childhood Trauma Questionnaire in an adolescent psychiatric population. J Am Acad Child Adolesc Psychiatry 1997, 36:340-348.
3. Bernstein D.P., Stein J.A., Newcomb M.D., Walker E., Pogge D., Ahluvalia T., et al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl 2003, 27:169-190.
4. Bernstein D.P., Stein J.A., Newcomb M.D., Walker E., Pogge D., Ahluvalia T., et al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl 2003, 27:169-190.
5. Binder E.B., Bradley R.G., Liu W., Epstein M.P., Deveau T.C., Mercer K.B., et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008, 299:1291-1305.
6. Bradley R.G., Binder E.B., Epstein M.P., Tang Y., Nair H.P., Liu W., et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 2008, 65:190-200.
7. Cubells J.F., Zabetian C.P. Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology (Berl) 2004, 174(4):463-476.
8. Cubells J.F., van Kammen D.P., Kelley M.E., Anderson G.M., O'Connor D.T., Price L.H., et al. Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet 1998, 102:533-540.
9. Cubells J.F., Kranzler H.R., McCance-Katz E., Anderson G.M., Malison R.T., Price L.H., et al. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry 2000, 5:56-63.
10. Cubells J.F., Price L.H., Meyers B.S., Anderson G.M., Zabetian C.P., Alexopoulos G.S., et al. Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression. Biol Psychiatry 2002, 51:358-364.
11. De Bellis M.D., Lefter L., Trickett P.K., Putnam F.W. Urinary catecholamine excretion in sexually abused girls. J Am Acad Child Adolesc Psychiatry 1994, 33:320-327.
12. Delahanty D.L., Nugent N.R., Christopher N.C., Walsh M. Initial urinary epinephrine and cortisol levels predict acute PTSD symptoms in child trauma victims. Psychoneuroendocrinology 2005, 30:121-128.
13. Foa E.B., Tolin D.F. Comparison of the PTSD Symptom Scale-Interview Version and the Clinician-Administered PTSD scale. J Trauma Stress 2000, 13:181-191.
14. Foa E.B., Riggs D.S., Dancu C.V., Rothbaum B.O. Reliability and validity of a brief instrument for assessing posttraumatic stress disorder. J Trauma Stress 1993, 6:459-473.
15. Geracioti T.D., Baker D.G., Ekhator N.N., West S.A., Hill K.K., Bruce A.B., et al. CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry 2001, 158:1227-1230.
16. Geracioti T.D., Baker D.G., Kasckow J.W., Strawn J.R., Mulchahey J.Jeffrey, Dashevsky B.A., et al. Effects of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder. Psychoneuroendocrinology 2008, 33:416-424.
17. Gillespie CF, Bradley B, Mercer K, Smith AK, Conneely K, Gapen M, Weiss T, Schwartz A, Cubells JF, Ressler KJ. in press. Trauma exposure and stress-related disorders in inner city primary care patients. Gen Hosp Psychiatry 2009; 31.
18. Glover D.A., Powers M.B., Bergman L., Smits J.A., Telch M.J., Stuber M. Urinary dopamine and turn bias in traumatized women with and without PTSD symptoms. Behav Brain Res 2003, 144:137-141.
19. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959, 32:50-55.
20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
21. Hamner M.B., Diamond B.I. Elevated plasma dopamine in posttraumatic stress disorder: a preliminary report. Biol Psychiatry 1993, 33:304-306.
22. Hamner M.B., Gold P.B. Plasma dopamine beta-hydroxylase activity in psychotic and non-psychotic post-traumatic stress disorder. Psychiatry Res 1998, 77:175-181.
23. Heim C., Nemeroff C.B. Neurobiology of posttraumatic stress disorder. CNS Spectr 2009, 14:13-24.
24. Kohnke M.D., Zabetian C.P., Anderson G.M., Kolb W., Gaertner I., Buchkremer G., et al. A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function. Biol Psychiatry 2002, 52:1151-1158.
25. Lemieux A.M., Coe C.L. Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women. Psychosom Med 1995, 57:105-115.
26. Markianos E.S., Nystrom I., Reichel H., Matussek N. Serum dopamine-beta-hydroxylase in psychiatric patients and normals. Effect of d-amphetamine and haloperidol. Psychopharmacology (Berl) 1976, 50:259-267.
27. Mellman T.A., Kumar A., Kulick-Bell R., Kumar M., Nolan B. Nocturnal/daytime urine noradrenergic measures and sleep in combat-related PTSD. Biol Psychiatry 1995, 38:174-179.
28. Mustapic M., Pivac N., Kozaric-Kovacic D., Dezeljin M., Cubells J.F., Muck-Seler D. Dopamine beta-hydroxylase (DBH) activity and -1021C/T polymorphism of DBH gene in combat-related post-traumatic stress disorder. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:1087-1089.
29. Schwartz A.C., Bradley R.L., Sexton M., Sherry A., Ressler K.J. Posttraumatic stress disorder among African Americans in an inner city mental health clinic. Psychiatr Serv 2005, 56:212-215.
30. Sher L., Oquendo M.A., Li S., Burke A.K., Grunebaum M.F., Zalsman G., et al. Higher cerebrospinal fluid homovanillic acid levels in depressed patients with comorbid posttraumatic stress disorder. Eur Neuropsychopharmacol 2005, 15:203-209.
31. Southwick S.M., Bremner J.D., Rasmusson A., Morgan C.A., Arnsten A., Charney D.S. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry 1999, 46:1192-1204.
32. Strawn J.R., Geracioti T.D. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress Anxiety 2008, 25:260-271.
33. Tang Y., Anderson G.M., Zabetian C.P., Kohnke M.D., Cubells J.F. Haplotype-controlled analysis of the association of a non-synonymous single nucleotide polymorphism at DBH (+ 1603C→T) with plasma dopamine beta-hydroxylase activity. Am J Med Genet B Neuropsychiatr Genet 2005, 139:88-90.
34. Tang Y., Buxbaum S.G., Waldman I., Anderson G.M., Zabetian C.P., Kohnke M.D., et al. A single nucleotide polymorphism at DBH, possibly associated with attention-deficit/hyperactivity disorder, associates with lower plasma dopamine beta-hydroxylase activity and is in linkage disequilibrium with two putative functional single nucleotide polymorphisms. Biol Psychiatry 2006, 60:1034-1038.
35. Tang Y.L., Epstein M.P., Anderson G.M., Zabetian C.P., Cubells J.F. Genotypic and haplotypic associations of the DBH gene with plasma dopamine beta-hydroxylase activity in African Americans. Eur J Hum Genet 2007, 15:878-883.
36. Vermetten E., Bremner J.D. Circuits and systems in stress. II. Applications to neurobiology and treatment in posttraumatic stress disorder. Depress Anxiety 2002, 16:14-38.
37. Wei J., Ramchand C.N., Hemmings G.P. Possible control of dopamine beta-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals. Hum Genet 1997, 99:52-55.
38. Weinshilboum R.M. Human biochemical genetics of plasma dopamine-beta-hydroxylase and erythrocyte catechol-o-methyltransferase. Hum Genet 1978, Suppl:101-112.
39. Wilson A.F., Elston R.C., Siervogel R.M., Tran L.D. Linkage of a gene regulating dopamine-beta-hydroxylase activity and the ABO blood group locus. Am J Hum Genet 1988, 42(1):160-166.
40. Yehuda R., Southwick S., Giller E.L., Ma X., Mason J.W. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J Nerv Ment Dis 1992, 180:321-325.
41. Yehuda R., Siever L.J., Teicher M.H., Levengood R.A., Gerber D.K., Schmeidler J., et al. Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder. Biol Psychiatry 1998, 44:56-63.
42. Zabetian C.P., Anderson G.M., Buxbaum S.G., Elston R.C., Ichinose H., Nagatsu T., et al. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 2001, 68:515-522.
43. Zabetian C.P., Buxbaum S.G., Elston R.C., Kohnke M.D., Anderson G.M., Gelernter J., et al. The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity. Am J Hum Genet 2003, 72:1389-1400.